PRESS RELEASE published on 11/07/2024 at 16:23, 16 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.16% stake in SEGRO plc. Also making disclosures related to Tritax EuroBox plc. Dealings include purchase and sale of 10p ordinary securities Securities The Vanguard Group Disclosures SEGRO PLC Tritax EuroBox Plc
PRESS RELEASE published on 11/07/2024 at 16:21, 16 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc The Vanguard Group, Inc. discloses 1.55% interest in Tritax EuroBox plc. Also making disclosures in respect of SEGRO plc. Details include 12,480,660 relevant securities owned Securities Disclosure Vanguard Group SEGRO PLC Tritax EuroBox Plc
PRESS RELEASE published on 11/07/2024 at 16:20, 16 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc The Vanguard Group, Inc. discloses 3.94% stake in TI Fluid Systems plc. Sale of 7,753 securities at 1.64 GBP per unit. Position disclosed on 06 November 2024 Vanguard Group Financial Disclosure Stake Disclosure TI Fluid Systems Plc Sell Securities
PRESS RELEASE published on 11/07/2024 at 16:18, 16 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: StoneX Group Inc. The Vanguard Group, Inc. discloses a 5.96% interest in StoneX Group Inc. on 06 November 2024, involving sale and purchase of securities Securities Disclosure The Vanguard Group Purchase StoneX Group Inc.
BRIEF published on 11/07/2024 at 16:12, 16 days 17 hours ago The Vanguard Group Discloses Position in Smith (DS) plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Smith (DS) Plc
BRIEF published on 11/07/2024 at 16:11, 16 days 17 hours ago The Vanguard Group Discloses Position in Spirent Communications Form 8.3 Takeover Code Vanguard Group Investment Disclosure Spirent Communications
PRESS RELEASE published on 11/07/2024 at 16:07, 16 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.91% stake in Smith (DS) plc. They bought 95,264 shares at 5.76 GBP and sold 5,327 shares at 5.78 GBP Shares Disclosure The Vanguard Group Smith (DS) Plc Stake
PRESS RELEASE published on 11/07/2024 at 16:06, 16 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses a 5.21% stake in Spirent Communications plc with 30,136,541 ordinary shares owned. Dealings on 06 November 2024 revealed sales of securities Financial Dealings Vanguard Group Stake Disclosure Spirent Communications Stock Sales
BRIEF published on 11/06/2024 at 15:09, 17 days 18 hours ago The Vanguard Group Discloses Position in StoneX Group Form 8.3 Takeover Code Vanguard Group Security Disclosure StoneX Group
BRIEF published on 11/06/2024 at 15:07, 17 days 18 hours ago Vanguard Group's Disclosure on International Paper Company Stake Form 8.3 Takeover Code Vanguard Group Stock Disclosure International Paper
Published on 11/22/2024 at 23:55, 1 day 10 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 10 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 10 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 11 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 15 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 16 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 17 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 3 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
